About this role
BioNTech is expanding its UK Medical Affairs organisation to support its transition to a commercial-stage oncology business. Based in London, this full-time Medical Science Liaison (MSL) role reports to the UK Senior Medical Director and serves as BioNTech’s scientific expert in solid tumours, leading external scientific engagement in lung cancer and additional indications as business needs evolve. The MSL will blend scientific exchange with strategic Medical Affairs activities, helping shape disease strategy, support launch readiness, and contribute to innovative research to transform cancer care for patients.
Responsibilities
- Act as BioNTech's scientific expert within the assigned disease area, delivering high-quality scientific exchange with healthcare professionals, scientific opinion leaders and other relevant stakeholders.
- Build and maintain trusted scientific partnerships across the UK oncology community to understand unmet medical needs, advance scientific understanding and improve patient outcomes.
- Develop and execute comprehensive stakeholder mapping and engagement plans aligned with UK and Global Medical Affairs priorities, generating medical insights that inform medical strategy and evidence generation.
- Contribute to the development and execution of disease area strategy, UK Medical Affairs plans and launch readiness activities through participation in strategic projects and cross-functional initiatives.
- Collaborate with clinical development and operations teams to support and accelerate global clinical trials conducted in the UK, leveraging UK Partnership initiatives, including study-site identification, participation in SIVs, patient-enrolment insights and smooth information exchange.
- Identify evidence gaps and scientific opportunities from external engagements to inform evidence generation planning and strategic priorities. Plan and deliver Advisory Boards, scientific education programmes and medical education activities, and represent BioNTech at scientific congresses and professional meetings.
- Maintain expert knowledge of the assigned disease area, including disease biology, biomarkers, clinical guidelines, treatment pathways, emerging science, healthcare system developments and the competitive landscape.
- Share scientific expertise and field insights across the organisation, contributing to a collaborative, innovative and high-performing Medical Affairs team.
- Ensure all activities are conducted in accordance with the ABPI Code of Practice, GCP, company policies and all applicable legal, ethical and regulatory requirements, including timely documentation and record-keeping.
Requirements
- Demonstrated scientific expertise in solid tumours, with current engagement in UK oncology communities; focus on lung cancer and potential additional indications as needed.
- Experience delivering high-quality scientific exchange with healthcare professionals, scientific opinion leaders and other stakeholders.
- Ability to build and maintain trusted scientific partnerships, develop stakeholder maps, and generate insights to inform medical strategy and evidence generation.
- Experience contributing to disease area strategy, UK Medical Affairs plans, and launch readiness through cross-functional collaboration.
- Ability to work with clinical development and operations teams to support UK-based clinical trials, including site identification, SIV participation, and leveraging partnership initiatives.
- Capability to identify evidence gaps, plan and deliver Advisory Boards and medical education activities, and represent the company at scientific congresses and meetings.
- Strong knowledge of disease biology, biomarkers, clinical guidelines, treatment pathways, emerging science, healthcare system developments and competitive landscape in the assigned area.
- Willingness to share expertise and insights across the organisation to support a collaborative Medical Affairs environment.
- Commitment to compliance with ABPI Code of Practice, GCP, company policies, and all applicable legal, ethical and regulatory requirements.